Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Penumbra, Inc. (NYSE: PEN).

Full DD Report for PEN

You must become a subscriber to view this report.


Recent News from (NYSE: PEN)

Penumbra, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference
ALAMEDA, Calif. , Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12 , 2018.  A webcast of the...
Source: PR Newswire
Date: November, 29 2018 16:05
Report: Exploring Fundamental Drivers Behind Resonant, Constellation Brands, Masimo, Tetraphase Pharmaceuticals, LivaNova, and Penumbra - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Resonant Inc. (NASDAQ:RESN), Constellation Brands Inc (NYSE:STZ), Masimo ...
Source: GlobeNewswire
Date: November, 29 2018 07:50
Penumbra (PEN) CEO Adam Elsesser on Q3 2018 Results - Earnings Call Transcript
Penumbra (PEN) Q3 2018 Earnings Conference Call November 5, 2018 5:00 PM ET Executives Dan Wilson - Director and Head of Business Development Adam Elsesser - Chairman, President and Chief Executive Officer Sri Kosaraju - Chief Financial Officer and Head of Strategy Analysts ...
Source: SeekingAlpha
Date: November, 05 2018 22:01
Penumbra beats by $0.12, beats on revenue
Penumbra (NYSE: PEN ): Q3 Non-GAAP EPS of $0.17 beats by $0.12 ; GAAP EPS of -$0.55 misses by $0.60 . Revenue of $111.8M (+33.3% Y/Y) beats by $8.21M . Press Release More news on: Penumbra, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: November, 05 2018 16:24
Penumbra, Inc. Reports Third Quarter 2018 Financial Results
ALAMEDA, Calif. , Nov. 5, 2018 /PRNewswire/ -- Penumbra, Inc.   (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter ended September 30, 2018. Revenue of $111.8 million in the third quarter of 2...
Source: PR Newswire
Date: November, 05 2018 16:05
Notable earnings after Monday's close
ACHC , AEL , AKCA , ANDE , APLE , APTS , ATRO , ATUS , AVD , AWR , BE , BHF , BKD , BKH , BKNG , CAR , CBT , CDEV , COHU , CRZO , CTRE , CXW , DCO , DCP , DRH , DVAX , ELF , EVBG , FMC , FN , FNV , FRGI , FRPT , FTDR , HHC , IFF , INSY , IPAR , ITRI , ...
Source: SeekingAlpha
Date: November, 04 2018 17:35
Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penumbra, Inc. (NYSE:PEN), Aetna Inc. (NYSE:AET), Littelfuse, Inc. (NASDA...
Source: GlobeNewswire
Date: October, 19 2018 07:35
Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018
ALAMEDA, Calif. , Oct. 15, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close on Monday, November 5, 2018 at 5:00 PM Eastern Time. A press release wit...
Source: PR Newswire
Date: October, 15 2018 16:05
Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90 percent of th...
Source: Business Wire
Date: September, 04 2018 07:05
Penumbra Launches Latest Advancements in Stroke Thrombectomy Aspiration Technology
Positive early clinical experience with new Penumbra JET™ Reperfusion Catheters and Penumbra ENGINE™ Aspiration Source Penumbra, Inc . (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumb...
Source: Business Wire
Date: September, 04 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-11134.63127.87136.5325125.27409,717
2018-12-10131.55132.58133.43128.70173,069
2018-12-07135.63131.72136.935129.80238,568
2018-12-06136.92136.31141.04131.40566,102
2018-12-04145.20139.33147.70138.695423,193

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1123,17228,65680.8626Short
2018-12-106239,1736.7917Cover
2018-12-072,1504,53747.3881Short
2018-12-0615,25321,46171.0731Short
2018-12-042,93915,23019.2974Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PEN.


About Penumbra, Inc. (NYSE: PEN)

Logo for Penumbra, Inc. (NYSE: PEN)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $5,380,979,650 - 05/25/2018
  • Issue and Outstanding: 34,262,844 - 04/24/2018

 


Recent Filings from (NYSE: PEN)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: July, 10 2018
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: July, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 08 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018

 

 


Daily Technical Chart for (NYSE: PEN)

Daily Technical Chart for (NYSE: PEN)


Stay tuned for daily updates and more on (NYSE: PEN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: PEN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PEN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PEN and does not buy, sell, or trade any shares of PEN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/